Diabetes

Top Story

For type 2 diabetes, intermittent vs. continuous energy restriction yields similar glycemic improvements

For type 2 diabetes, intermittent vs. continuous energy restriction yields similar glycemic improvements
July 20, 2018
FDA News

Dulaglutide label to reflect new safety, efficacy data in type 2 diabetes, CKD

July 20, 2018
Eli Lilly has updated the label for the once-weekly GLP-1 receptor agonist dulaglutide to reflect new safety and efficacy data reported for adults with type 2 diabetes…
In the Journals Plus

Diabetes increases risk for all cancers by 10%

July 20, 2018
Adults with diabetes have a 10% greater risk for developing any cancer vs. those without diabetes, whereas the disease confers a greater risk for overall and certain…

CREDENCE trial stopped early for favorable CKD findings with canagliflozin

July 19, 2018
The steering committee behind the phase 3 CREDENCE clinical trial, evaluating the efficacy and safety of the SGLT2 inhibitor canagliflozin vs. placebo for adults with…
More Headlines »
CME

Early Treatment of Diabetic Retinopathy and Diabetic Macular Edema: Optimal Use of Anti-VEGF Therapy for Vision Preservation and Restoration

This activity is supported by an educational grant from Genentech, Inc.

Diabetic retinopathy (DR) and diabetic macular edema (DME) are 2 of the most common causes of blindness among…
More »
Video
Meeting News

VIDEO: Antithrombotic therapy strategies in diabetes 'rapidly evolving'

July 19, 2018
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

CME

Advances in Insulin Formulations: Concentrated and Fixed-dose Insulin Formulations Can Improve Outcomes in Patients with Type 2 Diabetes Mellitus

This activity is supported by an educational grant from Novo Nordisk Inc.

There are approximately 150 million people worldwide that have diabetes mellitus and this number is expected to double…
More »